Dawn Biopharma is an investment platform controlled by the KKR Healthcare Strategic Growth Fund II, established to own a diverse portfolio of companies committed to the development of innovative medicines and therapies. Dawn Biopharma aims to provide flexible capital to innovators and thought leaders across the life sciences ecosystem with a shared vision of delivering life-changing medicines to patients in need.
Company Details
- Employees
- 5
- Founded
- -
- Industry
- Biotechnology
- Keywords
- Logos Capital.
Dawn Biopharma Questions
Dawn Biopharma's LinkedIn profile is https://www.linkedin.com/company/dawn-biopharma
Dawn Biopharma has
5 employees.
View email and phone details for 5
employees at Dawn Biopharma.
Dawn Biopharma's industry is
Biotechnology
Dawn Biopharma's top competitors are
Venrock Healthcare Capital Partners Lp,
Tcgx,
Logos Capital,
Gilde Healthcare,
Adcendo,
Healthcap,
Longview Ventures,
Dawn-Bio,
Pontifax Venture Capital,
Surveyor Capital.
Dawn Biopharma's categories are Biotechnology
Dawn Biopharma's founding year is 2022
